Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.49 USD
Change Today -0.80 / -4.37%
Volume 443.5K
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

RGLS

Industry Average

Ratio data TTM as of 12/31/2014

Profitability - regulus therapeutics inc (RGLS)

Return on Assets

Industry Comparison
-19.06%

Return on Equity

Industry Comparison
-50.28%

Return on Capital

Industry Comparison
-21.58%

Margin Analysis - regulus therapeutics inc (RGLS)

Gross Margin

Industry Comparison
-435.22%

Levered Free Cash Flow Margin

Industry Comparison
-278.80%

EBITDA Margin

Industry Comparison
-566.18%

SG&A Margin

Industry Comparison
150.38%

Asset Turnover - regulus therapeutics inc (RGLS)

Total Assets Turnover

Industry Comparison
0.1x

Accounts Receivables Turnover

Industry Comparison
43.5x

Fixed Assets Turnover

Industry Comparison
2.1x

Inventory Turnover

Industry Comparison
--
No data available

Credit Ratios - regulus therapeutics inc (RGLS)

Current Ratio

Industry Comparison
4.7x

Quick Ratio

Industry Comparison
4.5x

Long-Term Solvency - regulus therapeutics inc (RGLS)

Total Debt/Equity

Industry Comparison
17.72%

Total Liabilities/Total Assets

Industry Comparison
23.01%

Growth Over Prior Year - regulus therapeutics inc (RGLS)

Total Revenue

Industry Comparison
-60.81%

Tangible Book Value

Industry Comparison
41.74%

EBITDA

Industry Comparison
164.08%

Gross Profit

Industry Comparison
221.77%

Receivables

Industry Comparison
246.84%

Inventory

Industry Comparison
--
No data available

Diluted EPS Before Extra

Industry Comparison
164.98%

Capital Expenditures

Industry Comparison
43.25%

Cash From Ops.

Industry Comparison
39.46%

Levered Free Cash Flow

Industry Comparison
78.96%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $17.49 USD -0.80

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.82 AUD +0.03
Galena Biopharma Inc $1.45 USD +0.02
Marina Biotech Inc $0.61 USD -0.0077
Silence Therapeutics PLC 300.00 GBp -5.00
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 106.9x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 91.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.